Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

Wednesday’s trading has closed, but NVO is being traded in the after-hours session. After-Hours quote »
59.35
Delayed Data
As of 4:03pm ET
 +0.95 / +1.63%
Today’s Change
41.72
Today|||52-Week Range
59.49
+40.24%
Year-to-Date

Stock Price Forecast

The 32 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 62.40, with a high estimate of 74.86 and a low estimate of 40.24. The median estimate represents a +5.14% increase from the last price of 59.35.

Analyst Recommendations

The current consensus among 32 polled investment analysts is to Buy stock in Novo Nordisk. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.47
Sales
$4.0B
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -17.94%
 
 
 
 
 
 
Growthannually 17.17%
 
 
 
 
 
 

Sales

Growthquarterly 5.88%
 
 
 
 
 
 
Growthannually 11.84%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.